BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 30851101)

  • 1. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
    Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
    Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.
    Ikeda G; Matoba T; Ishikita A; Nagaoka K; Nakano K; Koga JI; Tsutsui H; Egashira K
    J Am Heart Assoc; 2021 Jun; 10(12):e019521. PubMed ID: 34056918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.
    Bajpai G; Bredemeyer A; Li W; Zaitsev K; Koenig AL; Lokshina I; Mohan J; Ivey B; Hsiao HM; Weinheimer C; Kovacs A; Epelman S; Artyomov M; Kreisel D; Lavine KJ
    Circ Res; 2019 Jan; 124(2):263-278. PubMed ID: 30582448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization.
    Zhao J; Li X; Hu J; Chen F; Qiao S; Sun X; Gao L; Xie J; Xu B
    Cardiovasc Res; 2019 Jun; 115(7):1205-1216. PubMed ID: 30753344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
    Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
    PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Extra Domain A of Fibronectin Reduces Acute Myocardial Ischaemia/Reperfusion Injury in Hyperlipidaemic Mice by Limiting Thrombo-Inflammation.
    Chorawala MR; Prakash P; Doddapattar P; Jain M; Dhanesha N; Chauhan AK
    Thromb Haemost; 2018 Aug; 118(8):1450-1460. PubMed ID: 29960272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate modulates post-infarction inflammation primarily by targeting monocytes or macrophages.
    Wang Z; Huang S; Sheng Y; Peng X; Liu H; Jin N; Cai J; Shu Y; Li T; Li P; Fan C; Hu X; Zhang W; Long R; You Y; Huang C; Song Y; Xiang C; Wang J; Yang Y; Liu K
    Cardiovasc Res; 2017 Apr; 113(5):475-487. PubMed ID: 28339742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
    Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
    Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.
    Nakano Y; Matoba T; Tokutome M; Funamoto D; Katsuki S; Ikeda G; Nagaoka K; Ishikita A; Nakano K; Koga J; Sunagawa K; Egashira K
    Sci Rep; 2016 Jul; 6():29601. PubMed ID: 27403534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction.
    Ishikita A; Matoba T; Ikeda G; Koga J; Mao Y; Nakano K; Takeuchi O; Sadoshima J; Egashira K
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway.
    Ding HS; Yang J; Yang J; Guo X; Tang YH; Huang Y; Chen Z; Fan ZX; Huang CX
    Mol Biol Rep; 2021 May; 48(5):3893-3901. PubMed ID: 34032975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
    Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
    Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway.
    Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
    Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
    Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse.
    Parapanov R; Lugrin J; Rosenblatt-Velin N; Feihl F; Waeber B; Milano G; Vergely C; Li N; Pacher P; Liaudet L
    Clin Sci (Lond); 2015 Jul; 129(2):187-98. PubMed ID: 25757463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.
    Bhindi R; Fahmy RG; McMahon AC; Khachigian LM; Lowe HC
    J Pathol; 2012 Jun; 227(2):157-64. PubMed ID: 22344601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury.
    Lu C; Ren D; Wang X; Ha T; Liu L; Lee EJ; Hu J; Kalbfleisch J; Gao X; Kao R; Williams D; Li C
    Biochim Biophys Acta; 2014 Jan; 1842(1):22-31. PubMed ID: 24140513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.